Back to Search
Start Over
Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
- Source :
-
Clinical Medicine Insights: Oncology . Jan-Dec2023, Vol. 17, p1-20. 20p. - Publication Year :
- 2023
-
Abstract
- BACKGROUND: Recent studies have shown that inflammatory indicators are closely related to the prognosis of patients with hepatocellular carcinoma, and they can serve as powerful indices for predicting recurrence and survival time after treatment. However, the predictive ability of inflammatory indicators has not been systematically studied in patients receiving transarterial chemoembolization (TACE). Therefore, the objective of this research was to determine the predictive value of preoperative inflammatory indicators for unresectable hepatocellular carcinoma treated with TACE. METHODS: Our retrospective research involved 381 treatment-naïve patients in 3 institutions, including the First Affiliated Hospital of Soochow University, Nantong First People's Hospital, and Nantong Tumor Hospital, from January 2007 to December 2020 that received TACE as initial treatment. Relevant data of patients were collected from the electronic medical record database, and the recurrence and survival time of patients after treatment were followed up. Least absolute shrinkage and selection operator (LASSO) algorithm was used to compress and screen the variables. We utilized Cox regression to determine the independent factors associated with patient outcomes and constructed a nomogram based on multivariate results. Finally, the nomogram was verified from discriminability, calibration ability, and practical applicability. RESULTS: Multivariate analysis revealed that the levels of aspartate aminotransferase-to-platelet ratio index (APRI) and lymphocyte count were independent influential indicators for overall survival (OS), whereas the levels of platelet-to-lymphocyte ratio (PLR) was an independent influential index for progression. Nomograms exhibited an excellent concordance index (C-index), in the nomogram of OS, the C-index was 0.753 and 0.755 in training and validation cohort, respectively; and in the nomogram of progression, the C-index was 0.781 and 0.700, respectively. The time-dependent C-index, time-dependent receiver operating characteristic (ROC), and time-dependent area under the curve (AUC) of the nomogram all exhibited ideal discrimination ability. Calibration curves significantly coincided with the standard lines, which indicated that the nomogram had high stability and low degree of over-fitting. Decision curve analysis revealed a wider range of threshold probabilities and could augment net benefits. The Kaplan-Meier curves for risk stratification indicated that the prognosis of patients varied significantly between risk categories (P < .0001). CONCLUSIONS: The developed prognostic nomograms based on preoperative inflammatory indicators revealed high predictive accuracy for survival and recurrence. It can be a valuable clinical instrument for guiding individualized treatment and predicting prognosis. [ABSTRACT FROM AUTHOR]
- Subjects :
- *PREOPERATIVE care
*PLATELET lymphocyte ratio
*INFLAMMATION
*MULTIVARIATE analysis
*CALIBRATION
*RESEARCH methodology
*CHEMOEMBOLIZATION
*RETROSPECTIVE studies
*ACQUISITION of data
*MEDICAL records
*DESCRIPTIVE statistics
*KAPLAN-Meier estimator
*PREDICTION models
*ELECTRONIC health records
*TUMOR markers
*HEPATOCELLULAR carcinoma
*ALGORITHMS
*PROPORTIONAL hazards models
*ASPARTATE aminotransferase
*OVERALL survival
Subjects
Details
- Language :
- English
- ISSN :
- 11795549
- Volume :
- 17
- Database :
- Academic Search Index
- Journal :
- Clinical Medicine Insights: Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 175226942
- Full Text :
- https://doi.org/10.1177/11795549231178178